hsa-miR-199b

ncRNA information

ncRNA name

hsa-miR-199b

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

Wnt/Ī²-catenin-ABCG2 signaling pathway

Cancer information

Cancer name

Colorectal Cancer

Cancer site

Colon, Rectum, and Anus

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Up

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/Ī²-catenin-ABCG2 signaling pathway in ALDHA1+ colorectal cancer stem cells.

Tissue resource

Experiment

qRT-PCR


Institute

Country

Continent